Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Fda crawled date : 2021 - 12 - 21 save search
KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs
Published: 2021-12-21 (Crawled : 22:00) - biospace.com/
KRMD | News | $2.06 -2.83% -2.91% 61K
|
Health Technology
|
| O: 0.33%
H: 1.97%
C: 0.66%
eedom60 freedom60 fda clearance drug
HPTN Studies Inform FDA’s Approval of ViiV Healthcare’s Long-Acting Cabotegravir Injections for HIV Prevention
Published: 2021-12-21 (Crawled : 22:00) - biospace.com/
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.0%
H: 0.17%
C: -0.87%
fda health thc approval injection hiv
Certara Announces FDA Renewal and Expansion of Certara’s Biosimulation Software for Reviewing Regulatory SubmissionsFDA holds more than 400 Simcyp™ and Phoenix™ software licenses across 12 divisions and offices
Published: 2021-12-21 (Crawled : 15:30) - biospace.com/
CERT | $16.19 -4.48% -4.69% 490K
|
|
| O: 1.27%
H: 3.34%
C: 2.58%
fda expansion license software submission
CytoDyn Receives Positive Response From FDA in Regard to its Phase 3, Registrational Trial in COVID-19 Critically Ill Population
Published: 2021-12-21 (Crawled : 14:30) - biospace.com/
CYDY | $0.146 0.06% 700K
|
Manufacturing
|
| O: 5.0%
H: 2.86%
C: 0.0%
covid-19 fda trial covid positive pons phase 3 response
Sol-Gel Technologies Announces Positive Update Related to FDA Review Status of EPSOLAY®
Published: 2021-12-21 (Crawled : 13:30) - biospace.com/
SLGL | $0.9001 5.04% 4.8% 3.5K
|
Health Technology
|
| O: 1.43%
H: 0.14%
C: -3.39%
epsolay fda positive
Hepion Pharmaceuticals Announces FDA Clearance of IND Application for CRV431 in the Treatment of Liver Cancer
Published: 2021-12-21 (Crawled : 13:00) - hepionpharma.com
HEPA | $2.1 -1.41% -1.43% 28K
|
Health Technology
|
| O: 0.83%
H: 7.38%
C: 0.82%
crv431 treatment fda als clearance application liver fda clearance cancer
ANI Pharmaceuticals Announces FDA Approval and Imminent Launch of Rifabutin Capsules USP
Published: 2021-12-21 (Crawled : 12:30) - biospace.com/
ANIP S | $64.6 -1.34% -1.36% 180K
|
Health Technology
|
| O: 1.79%
H: 0.38%
C: 0.33%
fda als fda approval approval
Mainz BioMed Appoints Karen Richards as Vice President, Regulatory Affairs to Lead US FDA Approval Process
Published: 2021-12-21 (Crawled : 12:00) - biospace.com/
MYNZ | $0.9 -3.35% -3.47% 52K
|
|
| O: -0.78%
H: 5.04%
C: 3.14%
fda fda approval air approval
Aquestive Therapeutics Receives Notification from FDA that It Will Not Be Ready to Take Action by December 23, 2021 for the Company’s NDA for Libervant™ (diazepam) Buccal Film
Published: 2021-12-21 (Crawled : 06:00) - globenewswire.com
AQST | $4.505 14.92% 12.99% 5.8M
|
Health Technology
|
| O: -30.71%
H: 8.58%
C: 2.09%
fda therapeutics
FDA Approves Two New Indications for XARELTO® (rivaroxaban) to Help Prevent and Treat Blood Clots in Pediatric Patients
Published: 2021-12-21 (Crawled : 05:00) - prnewswire.com
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.18%
H: 0.02%
C: -0.51%
xarelto fda blood
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.